Achieving Aseptic Drying With Spray Drying Technologies - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Achieving Aseptic Drying With Spray Drying Technologies
Henrik Schwartzbach, senior process technologist at GEA Niro, explins why spray drying is seeing increased uptake in the pharma industry.

Pharmaceutical Technology Europe
Volume 23, Issue 9

How do aseptic spray dryers differ from non-aseptic spray dryers?

Pharmaceutical production under aseptic conditions has to be a validated process that fulfills the requirements established by the relevant authorities, including requirements for how to sterilise the plant and for maintaining of sterility throughout the full production run. An aseptic spray dryer is differentiated from a non-aseptic one only in the requirements for sterilisation and can be used for the same processes, such as particle engineering, lenient drying, scalability and use of organic solvents, as a non-aseptic spray dryer.

The challenges of using spray drying in aseptic production mainly relate to three areas:

  • plant sterilisation
  • maintaining sterility during production
  • product handling (e.g., filling of vials).

A fundamental difference between the use of a spray dryer compared with aseptic liquid and typically aseptic-lyophilised formulations is that it requires aseptic powder filling into vials as opposed to aseptic liquid filling. In the case of lyophilisation, vials must also be loaded prior to the drying process. However, aseptic powder filing is a well-established technology with several providers in the market.

To ensure that sterility is maintained during spray drying, all gas entering and leaving the sterile drying zone must be adequately filtered. The liquid formulation must also be adequately filtered. However, this may not always be possible, in which case sterility must be ensured through other means, such as preparing the formulation under aseptic conditions using sterile components.

What methods are used for sterilising spray dryers?

An accepted method for the sterilisation of spray dryers that meets the requirements from drug approval authorities is the key for wider use of spray drying in aseptic production. Traditionally, spray drying sterilisation methods have included:

  • off-line sterilisation in a autoclave or sterilisation oven
  • in-place sterilisation by dry heat
  • in-place sterilisation by steam.

Off-line sterilisation is ideal for small plants that can be dismounted and assembled aseptically after sterilisation (e.g., inside an isolator). Small plants and the associated ductwork have a large surface area to volume ratio, which makes dry heat sterilisation problematic, and off-line sterilisation offers a less complex solution compared with in-place sterilisation by steam.

In-place sterilisation by dry heat takes advantages of the fact that a spray dryer is designed for hot gas. However, the high temperature requirements (typically 170 C) and the limited heat capacity of air or nitrogen make it difficult to heat up the inside surface of plant and ductwork where cold bridges are present.

Sterilisation by steam has been the preferred method for sterilisation in the pharmaceutical industry for decades and is used extensively for lyophilisers. This method is also applicable for spray dryers if it is designed as a pressure vessel.

A novel sterilisation process for lyophilisers is H2O2, which is approved by both the FDA and the EMA. For spray dryers, H2O2 or other gases have not been used for sterilisation. Compared with the internal surfaces of a lyophiliser for vials, the internal surfaces of a spray dryer are direct product contact surfaces. H2O2 or similar gases have not been used because they have not yet found general acceptance as means for sterilising direct product contact surfaces.

Are there any difficulties associated with cleaninplace in preparing for aseptic spray drying

Clean-in-place (CIP) is a wellknown operation. As long as the CIP solutions do not impair the sterilisation of the spray dryer, they are no different from other high-performance CIP systems used for non-aseptic pharmaceutical spray drying.

A filter integrity test is performed at the beginning and end of each cycle to ensure that the filters are functioning as intended. Sterilisation is done by Steam-in-place (SIP) of the complete spray dryer, including feed line, nozzle and sterile filters. SIP is performed as an evacuation and heating sequence followed by a steam sterilisation sequence at a minimum 121 C for 20 min. The evacuation and heating sequence consists of a series of evacuations separated by steam injections, which ensures the removal of air and heats the dryer prior to the sterilisation sequence itself. The removal of non-condensables and the heating sequence is important for the plant to be fully sterilised. Crucial parameters include not only the sequence of evacuation and steam injection, but also the duration of the steps and the pressure by which they are conducted.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology Europe,
Click here